Eucure (Beijing) Biopharma Co., Ltd   Report issue

For profit Phase 1 Phase 2
Founded: Beijing China (2016)

Organization Overview

First Clinical Trial
2020
NCT04357756
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Eucure (Beijing) Biopharma Co., Ltd

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 12
  • # of Trial APIs: 8